Open Access

A multi-country snapshot study of pain in people with haemophilia


Cite

Pain in people with haemophilia remains an ill-defined and treated comorbidity. This study looks at its prevalence, severity, influencing factors and management across a range of countries, and calls for age and developmentally appropriate pain assessment in routine care.
Pain in people with haemophilia remains an ill-defined and treated comorbidity. This study looks at its prevalence, severity, influencing factors and management across a range of countries, and calls for age and developmentally appropriate pain assessment in routine care.

Figure 1

Respondents with and without pain by age group
Respondents with and without pain by age group

Participant demographics (N=209)

CLINICAL DATAN%
Haemophilia typeA18186.6%
B2511.9%
Unknown31.5%
Haemophilia severitySevere14870.8%
Moderate2813.4%
Mild3114.8%
Unknown21.0%
Inhibitor statusCurrent2813.4%
Past199.1%
Never16277.5%
Patient age (years)8–152813.4%
16–253014.4%
26–354521.5%
36–557033.5%
>563617.2%
Treatment regimenOn-demand6129.2%
Prophylaxis12157.9%
On-demand and prophylaxis209.6%
Unknown73.3%
Reason for visitMedical review11555.2%
Physio/nurse review5325.3%
Bleed2913.8%
Previous bleed/surgery125.7%

EQ-5D VAS scores by age group

AGE GROUP (YEARS)MEAN VAS SCORE ±SDMEDIAN (RANGE)
8–150.88±0.191 (0.42–1.00)
16–250.74±0.210.78 (0.38–1.00)
26–350.81±0.180.77 (0.50–1.00)
36–550.56±0.310.60 (−0.07–1.00)
>560.57±0.260.58 (0.13–1.00)
Overall0.66±0.280.7 (−0.07–1.00)
eISSN:
2055-3390
Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Basic Medical Science, other, Clinical Medicine, Pharmacy, Pharmacology